Posts tagged OBGYN
The FDA Approves the First Postpartum Depression Pill in the US
The FDA Approves the First Postpartum Depression Pill in the US

The future of patients' outcomes with postpartum depression is very promising, after seeing evidence of effectiveness from clinical trials of zuranolone, a new pill to treat the mental disorder.

Read More
Health, WellnessIsabel CantorU.S. Food and Drug AdministrationIsabel Cantor, Postpartum depression, Postpartum, depression, Women, United States, FDA, Food and Drug Administration, zuranolone, Zurzuvae, Dr. Tiffany R. Farchione, Tiffany Farchione, FDA Division of Psychiatry, Psychiatry, Center for Drug Evaluation and Research, FDA Center for Drug Evaluation and Research, Dr. Kristina Deligiannidis, Kristina Deligiannidis, Institute of Behavioral Science, Feinstein Institutes for Medical Research, clinical trial, clinical trials, Dr. Darien Sutton, Darien Sutton, ABC News Medical Contributor, ABC News, ABC, Drug Enforcement Administration, Catherine Monk, Obstetrics, Gynecology, OBGYN, Columbia University, Columbia, Vagelos College of Physicians and SurgeonsComment